Bryce Holmgren, MD
Anesthesiology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Cep America - Anesthesia PC · 849 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Holmgren’s office at (408) 947-2500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A153895 · Current
Licensed to practise in California · since 2018 · expires 2028-02-29 · University of Minnesota Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$13,547
Medicare paid this office $13,547 for 64 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Anesthesia for lens surgery | 11 | $1,354 | $123 |
Who their Medicare patients are
64 Original Medicare patients in 2024. Average age 75 · Women 58% · Also on Medicaid 59% · Health risk score 2.73. Sicker patients than 9 in 10 peers; the typical anesthesiology clinician is at 1.54.
Conditions among them: High blood pressure 75% · Diabetes 63% · Chronic kidney disease 44% · Coronary heart disease 39% · Heart failure 34% · Depression 30% · Atrial fibrillation 28% · Stroke 20%.
The office billed $165,124, Medicare allowed $17,002 and paid $13,547; for 81 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 64 | 81 | 75 | 2.73 | $165,124 | $13,547 |
| 2023 | 79 | 96 | 73 | 2.70 | $196,948 | $17,209 |
| 2022 | 107 | 131 | 73 | 2.46 | $241,187 | $22,314 |
| 2021 | 142 | 473 | 72 | 2.97 | $293,402 | $32,165 |
| 2020 | 443 | 10,042 | 67 | 1.32 | $1,385,746 | $261,098 |
| 2019 | 175 | 3,013 | 67 | 1.32 | $349,502 | $71,319 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 14 | $1,751 | $125 |
2022: 2 services
| Anesthesia for lens surgery | 19 | $2,449 | $129 |
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 11 | $1,466 | $133 |
2021: 6 services
| Injection, methylprednisolone acetate, 40 mg | 20 | $136 | None |
| Ringers lactate infusion, up to 1000 cc | 19 | $31 | None |
| Injection, fentanyl citrate, 0.1 mg | 13 | $9 | None |
| Injection, propofol, 10 mg | 16 | $7 | None |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 12 | $5 | $0 |
| Injection, midazolam hydrochloride, per 1 mg | 11 | $2 | None |
2020: 33 services
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 93 | $37,856 | $315 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 89 | $30,098 | $136 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 58 | $29,379 | $338 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 58 | $23,929 | $152 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 80 | $22,426 | $214 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 79 | $14,900 | $157 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 47 | $11,348 | $196 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 35 | $8,341 | $199 |
| Injection of substance into middle or upper spine canal using imaging guidance | 30 | $7,028 | $201 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 47 | $5,897 | $103 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 41 | $5,252 | $103 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 33 | $4,156 | $107 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 31 | $4,003 | $108 |
| Fluoroscopic guidance for needle placement | 32 | $3,419 | $85 |
| Injection of substance into lower spine canal using imaging guidance | 17 | $3,118 | $183 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 25 | $2,384 | $79 |
| Injection, methylprednisolone acetate, 40 mg | 227 | $2,264 | None |
| Ultrasonic guidance for needle placement | 33 | $1,689 | $46 |
| Aspiration and/or injection of fluid from large joint | 29 | $1,598 | $47 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 15 | $1,196 | $80 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 11 | $980 | $61 |
| Ringers lactate infusion, up to 1000 cc | 286 | $906 | None |
| Blood glucose (sugar) test performed by hand-held instrument | 86 | $470 | $3 |
| Injection, fentanyl citrate, 0.1 mg | 260 | $430 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 33 | $330 | None |
| Urine pregnancy test | 14 | $247 | $9 |
| Injection, propofol, 10 mg | 264 | $207 | None |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 214 | $127 | $0 |
| Blood test, clotting time | 16 | $93 | $4 |
| Injection, midazolam hydrochloride, per 1 mg | 266 | $86 | None |
| Injection, ketorolac tromethamine, per 15 mg | 51 | $53 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 26 | $45 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 44 | $22 | None |
2019: 27 services
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 26 | $10,042 | $335 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 38 | $8,308 | $219 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 25 | $7,646 | $139 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 15 | $6,915 | $329 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 14 | $4,954 | $150 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 29 | $4,530 | $156 |
| Destruction of peripheral nerve or branch | 19 | $4,268 | $74 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 17 | $3,469 | $193 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 13 | $2,934 | $196 |
| Injection of substance into lower spine canal using imaging guidance | 12 | $2,595 | $200 |
| Injection of substance into middle or upper spine canal using imaging guidance | 11 | $2,235 | $186 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 16 | $1,694 | $100 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 15 | $1,591 | $99 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 12 | $1,338 | $96 |
| Injection, methylprednisolone acetate, 40 mg | 136 | $1,097 | None |
| Fluoroscopic guidance for needle placement | 13 | $1,050 | $81 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 12 | $935 | $78 |
| Aspiration and/or injection of fluid from large joint | 11 | $418 | $38 |
| Ringers lactate infusion, up to 1000 cc | 129 | $291 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $153 | None |
| Injection, fentanyl citrate, 0.1 mg | 124 | $152 | None |
| Blood glucose (sugar) test performed by hand-held instrument | 45 | $148 | $3 |
| Injection, propofol, 10 mg | 106 | $58 | None |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 95 | $47 | $0 |
| Injection, midazolam hydrochloride, per 1 mg | 122 | $30 | None |
| Injection, ketorolac tromethamine, per 15 mg | 13 | $12 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 24 | $11 | None |
Medicaid work
$1,242 in 2021
Medicaid paid $1,242 for 125 billed services this clinician did in 2021, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Anesthesia for procedures on eye; lens surgery | 13 | $1,104 |
| Injection, methylprednisolone acetate, 40 mg | 15 | $63 |
| Ringers lactate infusion, up to 1000 cc | 24 | $41 |
| Fentanyl citrate injection | 19 | $15 |
| Injection, propofol, 10 mg | 19 | $12 |
| Injection, midazolam hydrochloride, per 1 mg | 19 | $3 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 16 | $3 |
| 2021 | 125 | 7 | 22 | $1,242 |
| 2020 | 215 | 7 | 37 | $262 |
See the largest Medicaid services in earlier years
2020
| Injection, methylprednisolone acetate, 40 mg | 16 | $117 |
| Ringers lactate infusion, up to 1000 cc | 44 | $65 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 19 | $27 |
| Fentanyl citrate injection | 35 | $20 |
| Injection, propofol, 10 mg | 41 | $19 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 23 | $7 |
| Injection, midazolam hydrochloride, per 1 mg | 37 | $5 |
Money from drug and device companies
$12 in 2024
| 2024 | 1 | 1 | None | $12 |
| 2019 | 3 | 10 | None | $450 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ambu | None | $12 | 1 payment
|
See the published payment
| Ambu | Meals · 2024-05-03 | None | $12 |
See earlier years (2019)
2019: $450
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $273 | 8 payments
|
| Nevro | Senza Spinal Cord Stimulation System | $144 | 1 payment
|
| Stryker | Ivs - Ivas | $33 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 61.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1366854226
- Licence
- CA A153895, KS 9408317, MN 66143California A153895: Current · expires 2028-02-29
- Trained
- University of Minnesota Medical School, 2014
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207L00000X (207L00000X)
- Mailing address
- 166 19th St S Ste 101, Sartell, MN, 56377
- NPI first listed
- 2014-05-27
- NPI last updated
- 2021-01-08
- NPI record certified
- 2021-01-08
This is when the NPI record was last certified, not a medical board exam.